← SynDRA
sincalide
SynDRA canonical compound SYN0041919 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CCKAR | CCKBR |
|---|
| Mechanism of action | cholecystokinin agonist |
|---|
All known targets
Mechanisms of action (all sources)
- CCKAR AGONIST
- Cholecystokinin A receptor agonist
- CCKBR FULL AGONIST
- cholecystokinin agonist
- CCKBR AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
ATC classes
- V04C · OTHER DIAGNOSTIC AGENTS
Cross-references
Synonyms
- KINEVAC
- Kinevac
- cholecystokinin-8
- SQ 19844
- Sincalida
- Cholecystokinin c-terminal octapeptide
- Cck c-terminal octapeptide
- Cck-8
- Cck-8s
- SQ-19844
- CCK-8
- cholecystokinin 8
- cholecystokinin fragment 26-33 amide (sulphated)
- CCK-8 (sulphated)
- cholecystokinin C-terminal octapeptide
- CCK C-terminal octapeptide
- CCK-8S
- sincalide (usp impurity)
- M03GIQ7Z6P
- Sincalidum
- Syncalide
- H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Cholecystokinin octapeptide
- DTXCID4028543
- CCK-OP
- OP-CCK
- SQ19844
- SQ19,844
- RefChem:57816
- SQ 19,844
- Cholecystokinin Pancreozymin C-Terminal Octapeptide
- V04CC03
- 3-10-Caerulein, 5-L-methionine-
- MFCD00079849
- C49H62N10O16S3
- CAS-25126-32-3
- Human CCK-8
Reported adverse events
Look up sincalide in the interactive SynDRA portal →